K5F.F GENENTA SCIENCE(SP.ADR)/1
- Market cap
- EUR 25.6M
- P/E
- -
- P/B
- 1.17x
- ROE
- -29.9%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Dec 2025.
Is K5F.F undervalued?
Graham numberThe Graham number of GENENTA SCIENCE(SP.ADR)/1 cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
GENENTA SCIENCE(SP.ADR)/1 fundamental analysis
No fundamental analysis for GENENTA SCIENCE(SP.ADR)/1 yet.
GENENTA SCIENCE(SP.ADR)/1 stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About GENENTA SCIENCE(SP.ADR)/1
Genenta Science S.p.A. operates as a strategic consolidator that focuses on acquiring ownership of privately held companies operating in Italian national-security-regulated sectors. Its activities and acquisition strategy covers aerospace, defense, national security, and biotechnology/biosecurity. Genenta Science S.p.A. was incorporated in 2014 and is headquartered in Milan, Italy.
Full company profileGENENTA SCIENCE(SP.ADR)/1 financial statements
GENENTA SCIENCE(SP.ADR)/1 annual financial statements (EUR; K = thousand, M = million, B = billion, T = trillion)
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | -5.54M | -11.0M | -11.7M | -9.76M | -6.60M |
| EBITDA | - | -11.0M | -11.7M | -9.72M | -6.58M |
| Net Income | -5.53M | -8.48M | -11.6M | -8.91M | -6.53M |
| EPS | -0.30 | -0.47 | -0.64 | -0.49 | -0.28 |
| Balance Sheet | |||||
| Total Assets | 40.0M | 33.4M | 22.3M | 14.8M | 31.9M |
| Total Liabilities | 1.17M | 2.30M | 1.91M | 2.33M | 10.0M |
| Shareholders' Equity | 38.9M | 31.1M | 20.4M | 12.5M | 21.8M |
| Cash & Short-term Investments | 37.2M | 29.8M | 3.69M | 4.58M | 5.53M |
| Cash Flow | |||||
| Operating Cash Flow | -6.96M | -7.42M | -11.2M | -6.24M | -6.87M |
| Capital Expenditure | 9.01K | 27.1K | 13.8K | 4.47K | 7.63K |
| Free Cash Flow | -6.97M | -7.45M | -11.2M | -6.24M | -6.88M |
| Ratios | |||||
| ROE | -14.2% | -27.2% | -57.0% | -71.3% | -29.9% |
| ROA | -13.8% | -25.4% | -52.1% | -60.1% | -20.5% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
GENENTA SCIENCE(SP.ADR)/1 dividends
GENENTA SCIENCE(SP.ADR)/1 has not paid dividends in the last 5 fiscal years.
Who owns GENENTA SCIENCE(SP.ADR)/1
- Insiders 43.49%
- Institutions 5.53%
- Public & others 50.99%
- Shares outstanding 48.2M
- Free float 18.8M
GENENTA SCIENCE(SP.ADR)/1 company profile
- Company name
- GENENTA SCIENCE(SP.ADR)/1
- Ticker
- K5F.F
- Exchange
- Frankfurt Exchange
- Sector
- Industrials
- Industry
- Biotechnology
- Employees
- 9
- Fiscal year end
- December
- Address
- Via dell?Annunciata 31, Milan, MI, Italy, 20121
- Phone
- 39 02 29 00 10 55
- Website
- genenta.com
About GENENTA SCIENCE(SP.ADR)/1
Genenta Science S.p.A. operates as a strategic consolidator that focuses on acquiring ownership of privately held companies operating in Italian national-security-regulated sectors. Its activities and acquisition strategy covers aerospace, defense, national security, and biotechnology/biosecurity. Genenta Science S.p.A. was incorporated in 2014 and is headquartered in Milan, Italy.
GENENTA SCIENCE(SP.ADR)/1 management
4- Mr. Pierluigi ParacchiCo-Founder, Chairman, CEO & GM · born 1973
- Mr. Richard B. SlanskyChief Financial Officer · born 1958
- Mr. Gianfranco De NigrisVice President of Corporate Development
- Ms. Barbara RegoniniFinance Director · born 1973